间歇性跛行患者术前指南导向治疗完全依从性与主要不良肢体事件的关系
该回顾性研究分析2016至2023年间258例接受开放手术或血管内治疗的间歇性跛行患者,评估术前指南导向治疗(GDC)依从性对2年主要不良肢体事件(MALE)的影响。结果显示完全依从者2年无MALE生存率87.9%,非依从者66.6%(P<.01);完全依从者MALE风险显著降低(HR 0.24),部分依从无此获益。
要点
- 完全依从GDC者2年无MALE生存率87.9%,显著高于非依从者的66.6%。
- 完全依从GDC降低MALE风险(HR 0.24),部分依从未见获益(HR 0.99)。
- 多数跛行患者术前未完全遵循GDC,需优先提高依从性以改善预后。
核心结论
- 完全依从术前GDC对接受干预的跛行患者2年内MALE具有保护作用,部分依从可能不提供类似获益。
研究设计与样本
- 回顾性分析2016至2023年单中心258例接受开放手术或血管内治疗的间歇性跛行患者。
- GDC定义为记录严重生活方式受限、最佳药物治疗依从(抗血小板、降脂、戒烟)和完成运动治疗。
- 部分依从定义为满足1或2项组分,非依从定义为不满足任何组分。
主要发现
- 258例中非依从占13.9%,部分依从占73.3%,完全依从占12.8%。
- 2年MALE发生率为23.3%,主要因再次干预。
- Kaplan-Meier分析示非依从、部分依从、完全依从的2年无MALE生存率分别为66.6%、76.7%、87.9%(P<.01)。
- 多变量Cox回归示完全依从较非依从的MALE风险比为0.24(0.09, 0.69),部分依从为0.99(0.56, 1.74)。
关键数值与推荐
- GDC三组分:严重生活方式受限记录、最佳药物治疗依从、完成运动治疗。
- MALE定义为重大截肢或靶肢体重大开放/血管内再干预的复合终点。
临床怎么用
- 对间歇性跛行患者术前应评估并促进GDC完全依从,以降低2年MALE风险。
- 部分依从可能不足以提供保护,需确保所有GDC组分落实。
局限性
- 回顾性单中心设计可能限制普遍性。
- 样本量258例,完全依从者仅12.8%,亚组分析效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Society for Vascular Surgery recommends surgery be reserved for claudicants with severe lifestyle-limiting symptoms despite optimal medical therapy and supervised exercise therapy-the sum of these known as guideline-directed care (GDC). However, most claudicants do not receive the full spectrum of GDC prior to open surgery or endovascular intervention. We investigate the impact of complete vs partial vs nonadherence to preoperative GDC in claudicants and assess its impact on 2-year major adverse limb events (MALEs). METHODS: A retrospective analysis was performed on claudicants with open surgery or endovascular intervention at a tertiary care institution between 2016 and 2023. GDC was measured prior to surgery and defined as (1) severe lifestyle limitation documentation, (2) optimal medical therapy adherence (composite of single antiplatelet agent, lipid-lowering therapy, smoking cessation), and (3) exercise therapy completion. Partial adherence was defined by meeting one or two of these components, and nonadherence was defined by meeting none of the components. The primary outcome was 2-year MALE, defined as a composite of major amputation or major open/endovascular reintervention of the target limb. Statistical analysis included one-way analysis of variance, Pearson χ2 tests, Kaplan-Meier, and univariable and multivariable Cox regression modeling. RESULTS: Of the 258 claudicants receiving open surgery or endovascular intervention, 13.9% demonstrated nonadherence to GDC, 73.3% demonstrated partial adherence, and 12.8% demonstrated complete adherence. MALE was seen in 23.3% of claudicants at 2 years, primarily because of reinterventions. On Kaplan-Meier analysis, claudicants with nonadherence to GDC demonstrated a 2-year MALE-free survival of 66.6%, partial adherence with 76.7%, and complete adherence with 87.9% (P < .01). On multivariable Cox regression modeling, patients with complete guideline adherence demonstrated a decreased risk of MALE (hazard ratio, 0.24 [0.09, 0.69]) when compared with nonadherence, whereas partial adherence did not (hazard ratio, 0.99 [0.56, 1.74]). CONCLUSIONS: Complete adherence to preoperative GDC is protective against MALE in claudicants undergoing intervention out to 2 years postintervention, whereas partial adherence may not offer a similar benefit. Future studies must prioritize improving adherence rates prior to surgery in claudicants to ensure long-term risk mitigation and prevent complications.
引用
- Shi R, Bulatao N, Mukherjee R, et al. Comparing major adverse limb events in claudicants with complete, partial, and nonadherence to preoperative guideline-directed care. J Vasc Surg. 2026. PMID: 42486245. doi:10.1016/j.jvs.2026.06.164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。